Candida auris Causing Healthcare-Associated Infections

Share this content:
<i>Candida auris</i> Causing Healthcare-Associated Infections
Candida auris Causing Healthcare-Associated Infections

WEDNESDAY, July 6, 2016 (HealthDay News) -- The emerging multidrug-resistant yeast Candida auris is causing invasive healthcare-associated infections with high mortality internationally, according to a clinical alert to U.S. healthcare facilities published by the U.S. Centers for Disease Control and Prevention.

The CDC has received reports from international healthcare facilities that C. auris is causing invasive healthcare-associated infections associated with high mortality. Some C. auris strains have elevated minimum inhibitory concentrations to the three major antifungal classes.

Researchers from the CDC have developed interim recommendations for U.S. healthcare facilities and laboratories. These include reporting suspected patients with C. auris infection to state/local public health authorities and the CDC. Laboratory diagnosis should be performed using diagnostic devices based on matrix-assisted laser desorption/ionization-time of flight and/or molecular methods; specimens that cannot be identified by conventional methods should be forwarded to the CDC for further characterization. Healthcare facilities should exercise infection control for patients with C. auris colonization or infection until further information is available. As a result of anecdotal reports suggesting C. auris may persist in the environment, healthcare facilities should ensure thorough daily cleaning and disinfection of patients' rooms.

"Experience outside the United States suggests that C. auris has high potential to cause outbreaks in healthcare facilities," according to the report. "Given the occurrence of C. auris in nine countries on four continents since 2009, CDC is alerting U.S. healthcare facilities to be on the lookout for C. auris in patients."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

Post-op course reduces rate of surgical site infection within 30 days of C-section among obese women

Multicomponent Intervention Linked to Greater Drop in BP

Multicomponent Intervention Linked to Greater Drop in BP

Intervention beneficial over 18 months for low-income adults in Argentina with uncontrolled HTN

Total of 0.21 Years Lost Due to Opioid-Related Poisoning Deaths

Total of 0.21 Years Lost Due to Opioid-Related ...

Drug-related poisoning deaths up from 2000 to 2015, with most of the increase due to opioid deaths

is free, fast, and customized just for you!

Already a member?

Sign In Now »